Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-AEGIS ibuprofen after major gut surgery
ISRCTN18046426Phase 4Recruiting
- Sponsor
- Queen Mary University of London
- Start
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ibuprofen in postoperative pain (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Number of ibuprofen or other NSAID doses administered, Overall Benefit of Analgesia Score and 12 more. Started Mar 2026; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ISRCTN18046426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18046426.